Intra-Cellular raises $107.5 million in follow-on

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) raised $107.5 million through the sale of 6.1 million shares at $17.50 in a follow-on underwritten by Leerink; Cowen; Guggenheim Securities; and JMP Securities. Last Friday, Intra-Cellular said it planned to sell 5 million shares in the offering. The company -- which is moving from the OTCQB and is slated to start trading on NASDAQ on Friday -- first proposed to raise up to $115 million in the offering earlier this month. ...